Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for efficiently detecting anti-retina antibody in serum and application thereof

A technology for retinal and retinopathy, applied in the field of biomedicine, can solve the problems of a small number of detected ARAs, a single detection method, and a small sample content, and achieve the effects of reducing the blindness rate, high detection sensitivity, and easy operation.

Pending Publication Date: 2022-04-12
BEIJING INST OF OPHTHALMOLOGY
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, there is no uniform serological testing standard for AIR in the world. There are a large number of potential patients, and delays in treatment or blind treatment due to missed diagnosis and misdiagnosis are common.
Based on the limitations of previous studies, such as small sample size, small number of detected ARAs, and single detection method, it is necessary to propose a new detection method for ARAs in the serum of clinically suspected AIR patients.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for efficiently detecting anti-retina antibody in serum and application thereof
  • Method for efficiently detecting anti-retina antibody in serum and application thereof
  • Method for efficiently detecting anti-retina antibody in serum and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] Clinical suspected AIR patients included Standards and Excluded Standards Reference 2016 US Veneulitis Association Published in AJO's Diagnosis and Treatment Consensus on Non-Vocal Taroid AIR (NP-AIR) (P-AIR patients with malignant tumors, other clinical The signs are similar to this, see Table 1).

[0040] Table 1

[0041]

[0042] Experimental group: 58 patients with clinical suspected AIR, including 15 patients with P-AIR, 33 patients with NP-AIR.

[0043] Disease control group: 12 cases of patients with typical primary retinal pigmentation (RP) in patients with intraocular retransmitaria (RP) were selected according to the diagnosis of disease diagnosis.

[0044] Normal control group: No obvious retinal lesions were selected, 10 cases without obvious abnormal abnormalities.

[0045] Efficient detection of methods of ARAS in the serum of patients with AIR, including the following steps:

[0046] (1) Extract 5 ml of blood, place the extracted venous blood at 1500 rpm to...

Embodiment 2

[0071] The treatment programs were treated with 58 patients detected by Example 1 as follows:

[0072] Among the 15 P-Air patients, two newly diagnosed lung cancer patients received chemotherapy, and 13 P-Air patients had accepted the treatment of tumors (including resection of tumors, chemotherapy or radiotherapy). After testing, 12 patients were partially or / and whole body using glucocorticoids, and three patients chose to observe.

[0073] Among the 33 NP-AIR patients, 8 NP-AIR patients consolidated their own immune diseases. After testing, 26 patients started or continued to accept local or / and body sugar corticoids or cyclosporine treatment, 7 NP- AIR patient chose to observe.

[0074] Among the patients undergoing treatment, 30% (26 / 85) eyes were improved, 23% (16 / 85) patients were decreased, 53% (46 / 85) eyes were stable during the observation period.

[0075] Two types of retinal lesions have good response to Quannide (TA) or dexamethasone injection implants (ozurdex) i...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a method for efficiently detecting an anti-retina antibody (ARAs) in serum, which comprises the following steps: (1) extracting venous blood of a clinical suspected AIR patient, and centrifuging to obtain the serum of the patient; (2) taking retinal protein extracted from normal human retinal tissue homogenate as a reaction substrate, and detecting the number of antibody positive bands, namely the number of ARAs, in serum of a patient by adopting a western blot method; (3) with known human recombinant protein antigen as a reaction substrate, detecting and confirming ARAs types existing in serum of a patient by adopting a western blot method; (4) detecting the ARAs in the serum of the patient by adopting an immunofluorescence method, and positioning the ARAs in the normal human retina tissue slice to obtain the positioning of the ARAs in the serum of the patient in the retina tissue; and (5) according to the detection results of the ARAs in the serum of the patient obtained in the steps (2), (3) and (4), determining the number of the ARAs in the serum, the types of the ARAs in the serum and the positioning of the ARAs in the retina tissue, and establishing serological indexes of the clinical suspected AIR patient. The detection method disclosed by the invention is high in sensitivity and specificity and suitable for clinical early detection.

Description

Technical field [0001] The present invention belongs to the field of biomedical medicine, and in particular to a method of highly detecting serum antibody and its application thereof. Background technique [0002] Autoimmune Retinopathy, AIR is a class of immunfuminated blind eye diseases, including Paraneoplastic, P-Air and non-Paraneoplastic, NP- AIR) two major types. The clinical manifestations of Air of AIR include the loss of bindess painless subacute vision, ERG abnormal, serum in the serum - Anti-Retinal Antibodies, ARAS. P-AIR includes cancer-associated retinopathy, car-associated retinopathy, a melanoma-associated retinopathy melanoma-associated retinopathy, mar). Certain benign tumors also cause CAR-like changes. NP-AIR patients have not found tumors in patients, but are often accompanied by autoimmune diseases. At present, it is believed that AIR's pathogenesis is closely related to the existence of ARAS in serum. Due to external factors such as tumors or viruses, bact...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G01N33/68G01N33/58
Inventor 曾惠阳刘谦刘亚丽张敬学彭晓燕
Owner BEIJING INST OF OPHTHALMOLOGY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com